Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eva Åkesson is active.

Publication


Featured researches published by Eva Åkesson.


Nature Genetics | 2005

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

Maria Swanberg; Olle Lidman; Leonid Padyukov; Per Eriksson; Eva Åkesson; Maja Jagodic; Anna Lobell; Mohsen Khademi; Ola Börjesson; Cecilia M. Lindgren; Pia Lundman; Anthony J. Brookes; Juha Kere; Holger Luthman; Lars Alfredsson; Jan Hillert; Lars Klareskog; Anders Hamsten; Fredrik Piehl; Tomas Olsson

Antigen presentation to T cells by MHC molecules is essential for adaptive immune responses. To determine the exact position of a gene affecting expression of MHC molecules, we finely mapped a previously defined rat quantitative trait locus regulating MHC class II on microglia in an advanced intercross line. We identified a small interval including the gene MHC class II transactivator (Mhc2ta) and, using a map over six inbred strains combined with gene sequencing and expression analysis, two conserved Mhc2ta haplotypes segregating with MHC class II levels. In humans, a –168A → G polymorphism in the type III promoter of the MHC class II transactivator (MHC2TA) was associated with increased susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction, as well as lower expression of MHC2TA after stimulation of leukocytes with interferon-γ. We conclude that polymorphisms in Mhc2ta and MHC2TA result in differential MHC molecule expression and are associated with susceptibility to common complex diseases with inflammatory components.


American Journal of Human Genetics | 2005

A high-density screen for linkage in multiple sclerosis.

Stephen Sawcer; Maria Ban; Mel Maranian; Tai Wai Yeo; Alastair Compston; Andrew Kirby; Mark J. Daly; De Jager Pl; Emily Walsh; Eric S. Lander; John D. Rioux; David A. Hafler; Adrian J. Ivinson; Jacqueline Rimmler; Simon G. Gregory; Silke Schmidt; Margaret A. Pericak-Vance; Eva Åkesson; Jan Hillert; Pameli Datta; Annette Bang Oturai; Lars P. Ryder; Hanne F. Harbo; Anne Spurkland; Kjell-Morten Myhr; Mikko Laaksonen; David R. Booth; Robert Heard; Graeme J. Stewart; Robin Lincoln

To provide a definitive linkage map for multiple sclerosis, we have genotyped the Illumina BeadArray linkage mapping panel (version 4) in a data set of 730 multiplex families of Northern European descent. After the application of stringent quality thresholds, data from 4,506 markers in 2,692 individuals were included in the analysis. Multipoint nonparametric linkage analysis revealed highly significant linkage in the major histocompatibility complex (MHC) on chromosome 6p21 (maximum LOD score [MLS] 11.66) and suggestive linkage on chromosomes 17q23 (MLS 2.45) and 5q33 (MLS 2.18). This set of markers achieved a mean information extraction of 79.3% across the genome, with a Mendelian inconsistency rate of only 0.002%. Stratification based on carriage of the multiple sclerosis-associated DRB1*1501 allele failed to identify any other region of linkage with genomewide significance. However, ordered-subset analysis suggested that there may be an additional locus on chromosome 19p13 that acts independent of the main MHC locus. These data illustrate the substantial increase in power that can be achieved with use of the latest tools emerging from the Human Genome Project and indicate that future attempts to systematically identify susceptibility genes for multiple sclerosis will have to involve large sample sizes and an association-based methodology.


PLOS ONE | 2007

HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis

Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M. Roos; Eva Åkesson; Juni Palmgren; Jan Hillert

A recent high-density linkage screen confirmed that the HLA complex contains the strongest genetic factor for the risk of multiple sclerosis (MS). In parallel, a linkage disequilibrium analysis using 650 single nucleotide polymorphisms (SNP) markers of the HLA complex mapped the entire genetic effect to the HLA-DR-DQ subregion, reflected by the well-established risk haplotype HLA-DRB1*15,DQB1*06. Contrary to this, in a cohort of 1,084 MS patients and 1,347 controls, we show that the HLA-A gene confers an HLA-DRB1 independent influence on the risk of MS (P = 8.4×10−10). This supports the opposing view, that genes in the HLA class I region indeed exert an additional influence on the risk of MS, and confirms that the class I allele HLA-A*02 is negatively associated with the risk of MS (OR = 0.63, P = 7×10−12) not explained by linkage disequilibrium with class II. The combination of HLA-A and HLA-DRB1 alleles, as represented by HLA-A*02 and HLA-DRB1*15, was found to influence the risk of MS 23-fold. These findings imply complex autoimmune mechanisms involving both the regulatory and the effector arms of the immune system in the triggering of MS.


Genes and Immunity | 2002

A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis

Eva Åkesson; Annette Bang Oturai; J Berg; S. Fredrikson; Oluf Andersen; Hanne F. Harbo; Mikko Laaksonen; Kjell-Morten Myhr; Harald Nyland; Lars P. Ryder; Magnhild Sandberg-Wollheim; P. S. Sørensen; Anne Spurkland; Arne Svejgaard; Peter Holmans; A. Compston; Jan Hillert; Stephen Sawcer

Genetic factors influence susceptibility to multiple sclerosis but the responsible genes remain largely undefined, association with MHC class II alleles being the only established genetic feature of the disease. The Nordic countries have a high prevalence of multiple sclerosis, and to further explore the genetic background of the disease, we have carried out a genome-wide screen for linkage in 136 sibling-pairs with multiple sclerosis from Denmark, Finland, Norway and Sweden by typing 399 microsatellite markers. Seventeen regions where the lod score exceeds the nominal 5% significance threshold (0.7) were identified—1q11–24, 2q24–32, 3p26.3, 3q21.1, 4q12, 6p25.3, 6p21–22, 6q21, 9q34.3, 10p15, 10p12–13, 11p15.5, 12q21.3, 16p13.3, 17q25.3, 22q12–13 and Xp22.3. Although none of these regions reaches the level of genome-wide significance, the number observed exceeds the 10 that would be expected by chance alone. Our results significantly add to the growing body of linkage data relating to multiple sclerosis.


European Journal of Neurology | 2007

The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients

Cathrine Smestad; Boel Brynedal; Gudrun Jonasdottir; Åslaug R. Lorentzen; Thomas Masterman; Eva Åkesson; Anne Spurkland; B. A. Lie; J. Palmgren; Elisabeth G. Celius; Jan Hillert; Hanne F. Harbo

The human leucocyte antigen (HLA) class II haplotype DRB1*15–DQB1*06 (DR15–DQ6) is associated with susceptibility to multiple sclerosis (MS), and HLA class I associations in MS have also been reported. However, the influence of HLA class I and II alleles on clinical phenotypes in MS has not yet been completely studied. This study aimed at evaluating the impact of HLA‐A and ‐DRB1 alleles on clinical variables in Scandinavian MS patients. The correlation between HLA‐A or ‐DRB1 alleles and age at onset, disease course and Multiple Sclerosis Severity Score (MSSS) were studied in 1457 Norwegian and Swedish MS patients by regression analyses and Kruskal–Wallis rank sum test. Presence of HLA‐DRB1*15 was correlated with younger age at onset of disease (corrected P = 0.009). No correlation was found between HLA‐A and the variables studied. This study analysed the effect of HLA‐A on clinical variables in a large Scandinavian sample set, but could not identify any significant contribution from HLA‐A on the clinical phenotype in MS. However, associations between HLA‐DRB1*15 and age at onset of MS were reproduced in this extended Scandinavian MS cohort.


European Journal of Neurology | 2007

X chromosome inactivation in females with multiple sclerosis

Gun Peggy Knudsen; Hanne F. Harbo; Cathrine Smestad; Elisabeth G. Celius; Eva Åkesson; Annette Bang Oturai; Lars P. Ryder; Anne Spurkland; Karen Helene Ørstavik

The aetiology of multiple sclerosis (MS) is unknown. Autoimmune mechanisms are most probably involved. Loss of immunological tolerance to self‐antigens is a common feature of autoimmune disorders. Response to X‐linked self‐antigens could be influenced by X‐chromosome inactivation, and contribute to the gender bias observed in autoimmune disorders. Previous studies have indicated an association between skewed X inactivation and autoimmune thyroid disease and scleroderma. To investigate a potential role of X inactivation in MS, we compared the X‐inactivation pattern in 568 female MS patients with controls. We found no difference in degree of skewing between patients (median 64%) and controls (median 65%) (P = 0.474). The X‐inactivation pattern did thus not explain the female predominance of MS patients in general. As the aetiology of different subgroups of MS may differ, patients were grouped according to disease course: relapsing–remitting (RR‐MS), secondary progressive (SP‐MS) and primary progressive (PP‐MS). A comparison of the X‐inactivation pattern between subgroups indicated a possible difference in degree of skewing between patients with a progressive versus a relapsing course (P = 0.05).


Multiple Sclerosis Journal | 2004

Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs

Annette Bang Oturai; Lars P. Ryder; S. Fredrikson; Kjell-Morten Myhr; Elisabeth G. Celius; Hanne F. Harbo; Oluf Andersen; Eva Åkesson; Jan Hillert; Hans O. Madsen; Harald Nyland; Anne Spurkland; Pameli Datta; Arne Svejgaard; Per Soelberg Sørensen

Background: Investigation of coaffected sib pairs is one method to determine the genetic influence on the clinical presentatio n of many complex diseases, such as multiple sclerosis (MS). Investigation of the clinical concordance in coaffected sib pairs may be a prerequisite to identify genes that modify the clinical outcome. The aim of this study was to investigate a possible genetic influence on selected demographic and clinical variables among familial Scandinavian MS cases. Material and methods: We identified 136 C aucasian Scandinavian families with MS coaffected sib pairs from Denmark, Norway, and Sweden. C ohen’s kappa coefficient and the intraclass correlation coefficient were used to assess concordances in sib pairs. Furthermore, clinical features and HLA-DR2 carrier status were compared among the probands of sib pairs. Results: We found significant concordance of the disease course (k=0.28, PB-0.001) and adjusted age of onset (r =0.23, P=0.028). Among probands of sib pairs, HLA-DR2 carrier patients had a younger age of onset (P=0.024). Conclusion: A nalyses of Scandinavian coaffected sib pairs suggest that disease course and age of onset are partly under genetic control. Furthermore, HLA-DR2 in probands of sib pairs suggests importance for age of onset.


Journal of Neuroimmunology | 2006

Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.

Maria Ban; David R. Booth; Robert Heard; Graeme J. Stewart; An Goris; Koen Vandenbroeck; Bénédicte Dubois; Mikko Laaksonen; Jorma Ilonen; Mehdi Alizadeh; G. Edan; Marie Claude Babron; David Brassat; M. Clanet; Isabelle Cournu-Rebeix; Bertrand Fontaine; Gilbert Semana; Rene Goedde; Jörg T. Epplen; Alexandra Weber; Carmen Infante-Duarte; Frauke Zipp; Cecilia Rajda; Krisztina Bencsik; László Vécsei; Shirley Heggarty; Colin A. Graham; Stanley Hawkins; Maria Liguori; Patricia Momigliano-Richiardi

By combining all the data available from the Genetic Analysis of Multiple sclerosis in EuropeanS (GAMES) project, we have been able to identify 17 microsatellite markers showing consistent evidence for apparent association. As might be expected five of these markers map within the Major Histocompatibility Complex (MHC) and are in LD with HLA-DRB1. Individual genotyping of the 12 non-MHC markers confirmed association for three of them — D11S1986, D19S552 and D20S894. Association mapping across the candidate genes implicated by these markers in 937 UK trio families revealed modestly associated haplotypes in JAG1 (p=0.019) on chromosome 20p12.2 and POU2AF1 (p=0.003) on chromosome 11q23.1.


Journal of Neuroimmunology | 2003

Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients

Hanne F. Harbo; Pameli Datta; Annette Bang Oturai; Lars P. Ryder; Stephen Sawcer; Efrosini Setakis; Eva Åkesson; Elisabeth G. Celius; H Modin; Magnhild Sandberg-Wollheim; Kjell-Morten Myhr; Oluf Andersen; Jan Hillert; Per Soelberg Sørensen; Arne Svejgaard; Alastair Compston; Frode Vartdal; Anne Spurkland

We report the first two genome-wide screens for linkage disequilibrium between putative multiple sclerosis (MS) susceptibility genes and genetic markers performed in the genetically homogenous Scandinavian population, using 6000 microsatellite markers and DNA pools of approximately 200 MS cases and 200 controls in each screen. Usable data were achieved from the same 3331 markers in both screens. Nine markers from eight genomic regions (1p33, 3q13, 6p21, 6q14, 7p22, 9p21, 9q21 and Xq22) were identified as potentially associated with MS in both screens.


Journal of Neuroimmunology | 2008

The SH2D2A gene and susceptibility to multiple sclerosis.

Åslaug R. Lorentzen; Cathrine Smestad; Benedicte A. Lie; Annette Bang Oturai; Eva Åkesson; Janna Saarela; Kjell-Morten Myhr; Frode Vartdal; Elisabeth G. Celius; Per Soelberg Sørensen; Jan Hillert; Anne Spurkland; Hanne F. Harbo

We previously reported an association between the SH2D2A gene encoding TSAd and multiple sclerosis (MS). Here a total of 2128 Nordic MS patients and 2004 controls were genotyped for the SH2D2A promoter GA repeat polymorphism and rs926103 encoding a serine to asparagine substitution at amino acid position 52 in TSAd. The GA(16)-rs926103()A haplotype was associated with MS in Norwegians (OR 1.4, P=0.04). A similar trend was observed among Danes. In the independent Norwegian, Danish and Swedish sample sets the GA(16) allele showed a combined OR of 1.13, P=0.05. Thus, the present study shows that the SH2D2A gene may contribute to susceptibility to MS.

Collaboration


Dive into the Eva Åkesson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hanne F. Harbo

Oslo University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kjell-Morten Myhr

Haukeland University Hospital

View shared research outputs
Top Co-Authors

Avatar

Lars P. Ryder

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar

Maria Ban

University of Cambridge

View shared research outputs
Researchain Logo
Decentralizing Knowledge